Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for Prevention of Recurrence in CRSwNP After Surgery
NCT04596189Phase 4Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- May 2021
- Primary completion
- Apr 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Centre hospitalier de l’Université de Montréal. Started May 2021; status: completed.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT04596189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04596189.